Schimmelpennink Evert B.
SEC insider (Form 3/4/5 filer). CIK 0001713795. Director at Contineum Therapeutics, Inc. (CTNM) and 2 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 26, 2026. Located in SAN DIEGO, CA.
Companies Schimmelpennink Evert B. has filed insider reports for
- Contineum Therapeutics, Inc. (CTNM): Director
- LENZ Therapeutics, Inc. (LENZ): Director, Officer, President, CEO and Secretary
- iBio, Inc. (IBIO): Director
Schimmelpennink Evert B.
CIK: 0001713795
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 26, 2026CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
19K shares- - Mar 27, 2026LENZ
LENZ Therapeutics, Inc.
PurchaseDirect28.1K shares at avg. $8.95$251K - Jan 2, 2026LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
358.1K shares- - Nov 20, 2025IBIO
iBio, Inc.
AwardDirectStock Option (right to buy)
13.5K shares- - Jun 26, 2025CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
14.8K shares- - Mar 7, 2025LENZ
LENZ Therapeutics, Inc.
ExerciseDirect4.2K shares at avg. $1.04$4K - Jan 9, 2025LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
279.1K shares- - Nov 21, 2024IBIO
iBio, Inc.
AwardDirectStock Option (right to buy)
18.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2026 |  CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 19,000 | - | - | Direct |
| Mar 27, 2026 |  LENZ LENZ Therapeutics, Inc. | Purchase | 28,089 | $8.95 | $251,411 | Direct |
| Jan 2, 2026 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 358,100 | - | - | Direct |
| Nov 20, 2025 |  IBIO iBio, Inc. | Award Stock Option (right to buy) | 13,500 | - | - | Direct |
| Jun 26, 2025 | CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 14,750 | - | - | Direct |
| Mar 7, 2025 | LENZ LENZ Therapeutics, Inc. | Exercise | 4,200 | $1.04 | $4,368 | Direct |
| Jan 9, 2025 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 279,100 | - | - | Direct |
| Nov 21, 2024 | IBIO iBio, Inc. | Award Stock Option (right to buy) | 18,900 | - | - | Direct |
1-8 of 8 transactions